Sinha KM, Stephanou NC, Unciuleac MC, Glickman MS, Shuman S
Biochemistry. 2008 Sep 9;47(36):9355-64.
September 26, 2008
Fig 1. Orthogonal film based implant evaluation. Surgical clips identified for cavity delineation and dummy sources were placed in catheters for subsequent position digitization.
Arthur DW, Winter K, Kuske RR, Bolton J, Rabinovitch R, White J, Hanson WF, Wilenzick RM, McCormick B
Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):467-73.
September 25, 2008
Fig. 3b. Covariation of CD8 and SHP-1 levels limits the frequencies of hypo- and hyperresponsive cells. Computer model for T cell activation demonstrate how the EC50 for ppERK responsiveness is determined by both CD8 and SHP-1 levels.
Fig. 1. Transformation with plasmids carrying wild type (wt) human CHEK2, as well as the Y424H variant, represses the normally reduced viability due to Rad53 deletion in the Rad53-null sml1-null yeast S. cerevisiae.
Tischkowitz MD, Yilmaz A, Chen LQ, Karyadi DM, Novak D, Kirchhoff T, Hamel N, Tavtigian SV, Kolb S, Bismar TA, Aloyz R, Nelson PS, Hood L, Narod SA, White KA, Ostrander EA, Isaacs WB, Offit K, Cooney KA, Stanford JL, Foulkes WD
Cancer Lett. 2008 Oct 18;270(1):173-180.
September 18, 2008
Fig 2. Histologic examination of the tumor revealed discrete lobules of angiomatous tissue with inflammatory cells to the level of the muscular layer of the lower lip.
Kumar A, Joo WS, Meinke G, Moine S, Naumova EN, Bullock PA
J Virol. 2008 Sep;82(17):8849-62.
September 12, 2008
Fig. 1b. Schematic representation of how to submit trachelectomy margin at the time of frozen-section analysis. Trachelectomy opened after shave showing grossly visible tumor; distance to margin is measured grossly.
Park KJ, Soslow RA, Sonoda Y, Barakat RR, Abu-Rustum NR
Gynecol Oncol. 2008 Sep;110(3):316-23.
September 11, 2008
Fig. 4c. Assessment of LLC Tumor Volume, Microvessel Density, Necrosis, and Long-Term Tumor Growth in Mice Treated with Paclitaxel or Gemcitabine in Combination with DC101C57BL/6 mice bearing 500 mm3 LLC tumors were treated with paclitaxel (PTX) or gemcitabine (GEM) with or without DC101 administered 24 hr prior to the chemotherapy drug.
Today's science sparks archives
Today's science sparks archives - September 2008
